Summary: It's a new year and we have a lot to talk about! There's good news about clinical trials...the FDA has given a Breakthrough Therapy designation for the first MS treatment approved for children and teens living with MS...UCLA researchers have identified why estrogen seems to have real potential as a treatment for MS...pharmaceutical companies are suing California over prescription price transparency...and host Jon Strum will tell you why the pace of scientific discovery is going to increase in 2018.
